Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
8
8 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- CorabotaseIPN10200Phase 37 trials
Ipsen · Moderate to Severe Glabellar Lines, Spasticity, Moderate to Severe Upper Facial Lines
- IPN60340Phase 31 trial
Ipsen · Acute Myeloid Leukaemia (AML), Acute Myeloid Leukaemia
- ICT01Phase 21 trial
ImCheck Therapeutics, an Ipsen company · Solid Tumor, Adult, Hematopoietic/Lymphoid Cancer
- IPN01194Phase 21 trial
Ipsen · Melanoma, Head and Neck Squamous Cell Carcinoma, Pancreatic Ductal Adenocarcinoma
- IPN01195Phase 21 trial
Ipsen · Advanced Solid Tumor
- IPN01203Phase 21 trial
Ipsen · Advanced Solid Tumor, Metastatic Solid Tumor
- IPN60300Phase 21 trial
Ipsen · Locally Advanced Solid Tumor, Metastatic Solid Tumor
- IPN60350Phase 21 trial
Ipsen · Neoplasms, Neoplasm Metastasis, Neoplastic Processes
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.